Intellectual Property Law

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks. As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property. Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews. Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues. The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding. Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC). The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review. Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review.

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Custom text		Organization Sort ascending
Aug 27 2020	Chinese Utility Model Patent That Survived 19 Invalidation Attempts Leads to 1 Million RMB in Damages	Schwegman, Lundberg & Woessner, P.A.
Sep 29 2020	China National Intellectual Property Administration to Close from October 1 – 8, 2020	Schwegman, Lundberg & Woessner, P.A.
Sep 30 2014	PTAB Joinder Practice Update: Board Interprets 35 U.S.C. § 315(c) to Require Party Joinder	Schwegman, Lundberg & Woessner, P.A.
Oct 16 2020	Beijing Fines Alibaba 100,000 RMB for Malicious Trademark Filings	Schwegman, Lundberg & Woessner, P.A.
Nov 11 2020	Artificial Intelligence Cannot Be Patent Inventor in China’s Draft Amended Patent Examination Guidelines	Schwegman, Lundberg & Woessner, P.A.
Nov 17 2020	China’s Supreme People’s Court Releases Provisions on Evidence in Intellectual Property Civil Litigation	Schwegman, Lundberg & Woessner, P.A.
Nov 19 2020	China and U.S. Rank Even in Wireless Communication Patent Applications Worldwide Through October 2020	Schwegman, Lundberg & Woessner, P.A.
Oct 17 2014	Target Corp. Requests Rehearing of Denied Inter Partes Review by Expanded Patent Trial and Appeal Board Panel	Schwegman, Lundberg & Woessner, P.A.
Oct 21 2014	Biotechnology Industry Organization (BIO) Provides Supplemental Comments on PTO s.101 Guidelines	Schwegman, Lundberg & Woessner, P.A.
Apr 21 2017	Novartis AG, LTS et al. v. Noven Pharmaceuticals, Inc. – Prior Judicial Opinions Don’t Bind the PTAB	Schwegman, Lundberg & Woessner, P.A.
Jan 11 2021	Accusation of Chinese Patent Infringement Leads to Slander Lawsuit Victory	Schwegman, Lundberg & Woessner, P.A.
Feb 4 2021	Interesting Developments at the EPO	Schwegman, Lundberg & Woessner, P.A.
Feb 14 2021	Amgen v. Sanofi – How Wands Factors make Biotech Claims “Magically” Disappear	Schwegman, Lundberg & Woessner, P.A.
Feb 24 2021	New Balance Fails to Invalidate Chinese New Balance Trademark at Beijing Higher People’s Court	Schwegman, Lundberg & Woessner, P.A.
Mar 16 2021	China Ceases Publishing Patent Application Filings Data	Schwegman, Lundberg & Woessner, P.A.
Apr 1 2021	Bulgari Wins at Beijing’s Intellectual Property Court Invalidating Hijacker’s Serpenti Snake Head Trademark	Schwegman, Lundberg & Woessner, P.A.
Apr 12 2021	Suspended Prison Sentences, Fine and Civil Compensation for Infringement of Chinese Trademark ‘STIHL’	Schwegman, Lundberg & Woessner, P.A.
Jan 2 2015	Book Review: Post-Grant Proceedings Before the Patent Trial and Appeal Board	Schwegman, Lundberg & Woessner, P.A.
Apr 21 2021	Listen to: A Conversation with Janice Mueller, Author of Mueller on Patent Law	Schwegman, Lundberg & Woessner, P.A.
Apr 30 2021	China’s National Intellectual Property Administration Releases Top Ten Cases of Patent Reexamination for 2020	Schwegman, Lundberg & Woessner, P.A.
Jul 9 2021	China’s Patent Grants Accelerate By Over 50% in First Half of 2021	Schwegman, Lundberg & Woessner, P.A.
Apr 12 2011	PTO Issues Final Rule to Implement Prioritized Examination Track (Track I)	Schwegman, Lundberg & Woessner, P.A.
Oct 29 2021	Chinese Patent Office Closure Dates – 2022	Schwegman, Lundberg & Woessner, P.A.
Dec 10 2021	USPTO Sanctions Chinese Trademark Agency by Terminating Over 15,000 U.S. Trademark Applications For Egregious Misconduct in Defrauding the USPTO	Schwegman, Lundberg & Woessner, P.A.
Jan 10 2022	Novartis v. Accord – No Limits on Negative Limitations?	Schwegman, Lundberg & Woessner, P.A.
Feb 2 2022	Qualcomm v. Apple – Pyrrhic Victory for Qualcomm?	Schwegman, Lundberg & Woessner, P.A.
Sep 15 2011	Myriad Petition For Rehearing Denied	Schwegman, Lundberg & Woessner, P.A.
Feb 18 2022	European Union Challenges China at the WTO Over Anti-Suit Injunctions Preventing Patent Holders from Asserting Their Rights Outside of China	Schwegman, Lundberg & Woessner, P.A.

Subscribe to The 10 Latest Intellectual Property, Patent, Trademark & Copyright News Articles

Trending News